The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Inside HDACs with more selective HDAC inhibitors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hoque, M. A., Islam, M. N., Islam, M. S., Kato, T., Nishino, N., Ito, A., & Yoshida, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.029 · Cited by 4
RetractedGuindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376
Selection of Conserved Blocks from Multiple Alignments for Their Use in Phylogenetic Analysis
Castresana, J. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026334 · Cited by 10,508
Phylogeny.fr: robust phylogenetic analysis for the non-specialist
Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., Dufayard, J.-F., Guindon, S., Lefort, V., Lescot, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn180 · Cited by 4,700
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Meyer, K. D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C. E., & Jaffrey, S. R. (2012) · Cell · doi:10.1016/j.cell.2012.05.003 · Cited by 4,223
Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative
Anisimova, M., & Gascuel, O. (2006) · Systematic Biology · doi:10.1080/10635150600755453 · Cited by 2,693
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Structure and function of long noncoding RNAs in epigenetic regulation
Mercer, T. R., & Mattick, J. S. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2480 · Cited by 1,438
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
HDAC family: What are the cancer relevant targets?
Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.016 · Cited by 1,069
TreeDyn: towards dynamic graphics and annotations for analyses of trees
Chevenet, F., Brun, C., Bañuls, A.-L., Jacq, B., & Christen, R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-439 · Cited by 1,061
Yang, X.-J., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210599 · Cited by 940
Regulation of nucleosome dynamics by histone modifications
Zentner, G. E., & Henikoff, S. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2470 · Cited by 923 · cited 2×
“[88] have identified by screening N-[1,3,4]thiadiazol-2-yl an d N-thiazol-2yl sulfonamide groups as promising ZBG, with probabl y etter physicochemical properties than hydroxamic acids as demonstrated by their current clinical applications .”
BackgroundRational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., & Kozikowski, A. P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102758v · Cited by 801
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Disteche, C., Dubé, I., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 771
DNA methylation profiling in the clinic: applications and challenges
Heyn, H., & Esteller, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3270 · Cited by 746
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Kazantsev, A. G., & Thompson, L. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2681 · Cited by 711
Juergens, R. A., Wrangle, J., Vendetti, F. P., Murphy, S. C., Zhao, M., Coleman, B., Sebree, R., Rodgers, K., Hooker, C. M., Franco, N., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0214 · Cited by 686
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Mottamal, M., Zheng, S., Huang, T., & Wang, G. (2015) · Molecules · doi:10.3390/molecules20033898 · Cited by 680
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
Tummino, P. J., & Copeland, R. A. (2008) · Biochemistry · doi:10.1021/bi8002023 · Cited by 544
The multifaceted functions of sirtuins in cancer
Chalkiadaki, A., & Guarente, L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3985 · Cited by 496
Uncovering global SUMOylation signaling networks in a site-specific manner
Hendriks, I. A., D'Souza, R. C. J., Yang, B., Verlaan-de Vries, M., Mann, M., & Vertegaal, A. C. O. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2890 · Cited by 486
Histone deacetylases and cancer
Barneda-Zahonero, B., & Parra, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.003 · Cited by 446
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., & Gottesfeld, J. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio815 · Cited by 442
Mazur, P. K., Herner, A., Mello, S. S., Wirth, M., Hausmann, S., Sánchez-Rivera, F. J., Lofgren, S. M., Kuschma, T., Hahn, S. A., Vangala, D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3952 · Cited by 397
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Lobera, M., Madauss, K. P., Pohlhaus, D. T., Wright, Q. G., Trocha, M., Schmidt, D. R., Baloglu, E., Trump, R. P., Head, M. S., Hofmann, G. A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1223 · Cited by 376
β- N -acetylglucosamine (O-GlcNAc) is part of the histone code
Sakabe, K., Wang, Z., & Hart, G. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009023107 · Cited by 373
Inside HDAC with HDAC inhibitors
Bertrand, P. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.02.030 · Cited by 363
Self-citationVorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Duvic, M., & Vu, J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1111 · Cited by 344
The future of epigenetic therapy in solid tumours—lessons from the past
Azad, N., Zahnow, C. A., Rudin, C. M., & Baylin, S. B. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.42 · Cited by 335
HDAC inhibitor‐based therapies: Can we interpret the code?
New, M., Olzscha, H., & La Thangue, N. B. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.003 · Cited by 310
Pandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo‐Coco, F., Grignani, F., & Pelicci, P. G. (1991) · PubMed · Cited by 305
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Grant, C., Rahman, F., Piekarz, R., Peer, C., Frye, R., Robey, R. W., Gardner, E. R., Figg, W. D., & Bates, S. E. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.88 · Cited by 291
The functional interactome landscape of the human histone deacetylase family
Joshi, P., Greco, T. M., Guise, A. J., Luo, Y., Yu, F., Nesvizhskii, A. I., & Cristea, I. M. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.26 · Cited by 289
Cai, X., Zhai, H.-X., Wang, J., Forrester, J., Qu, H., Yin, L., Lai, C.-J., Bao, R., & Qian, C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901453q · Cited by 264
Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics
Hottiger, M. O. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034506 · Cited by 229
Belinostat: First Global Approval
Poole, R. M. (2014) · Drugs · doi:10.1007/s40265-014-0275-8 · Cited by 216
HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
Rai, M., Soragni, E., Jenssen, K., Burnett, R., Herman, D., Coppola, G., Geschwind, D. H., Gottesfeld, J. M., & Pandolfo, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001958 · Cited by 214
Epigenetic treatment of solid tumours: a review of clinical trials
Nervi, C., De Marinis, E., & Codacci-Pisanelli, G. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0157-2 · Cited by 213
Marcaurelle, L. A., Comer, E., Dandapani, S., Duvall, J. R., Gerard, B., Kesavan, S., Lee, M. D., Liu, H., Lowe, J. T., Marie, J.-C., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105119r · Cited by 210
Chou, J.-L., Huang, R.-L., Shay, J., Chen, L.-Y., Lin, S.-J., Yan, P. S., Chao, W.-T., Lai, Y.-H., Lai, Y.-L., Chao, T.-K., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-014-0036-2 · Cited by 206
Shipley, J. L., & Butera, J. N. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.04.002 · Cited by 200
Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
Kaluza, D., Kroll, J., Gesierich, S., Yao, T., Boon, R. A., Hergenreider, E., Tjwa, M., Rössig, L., Seto, E., Augustin, H. G., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.298 · Cited by 196
Auxiliary‐Mediated Site‐Specific Peptide Ubiquitylation
Chatterjee, C., McGinty, R. K., Pellois, J., & Muir, T. W. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200605155 · Cited by 179
Marek, L., Hamacher, A., Hansen, F. K., Kuna, K., Gohlke, H., Kassack, M. U., & Kurz, T. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301254q · Cited by 177
Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003645 · Cited by 173
HDAC inhibitors in parasitic diseases
Andrews, K. T., Haque, A., & Jones, M. K. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.97 · Cited by 161
Structural Basis for Sirtuin Activity and Inhibition
Yuan, H., & Marmorstein, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.372300 · Cited by 160
Bonavida, B., Baritaki, S., Huerta‐Yépez, S., Vega, M. I., Chatterjee, D., & Yeung, K. C. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.018 · Cited by 154
Bürli, R. W., Luckhurst, C. A., Aziz, O., Matthews, K. L., Yates, D., Lyons, K. A., Beconi, M., McAllister, G., Breccia, P., Stott, A. J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4011884 · Cited by 153
A Proton-Shuttle Reaction Mechanism for Histone Deacetylase 8 and the Catalytic Role of Metal Ions
Wu, R., Wang, S., Zhou, N., Cao, Z., & Zhang, Y. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103932d · Cited by 153
Cole, K. E., Dowling, D. P., Boone, M. A., Phillips, A. J., & Christianson, D. W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205972n · Cited by 153
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
Szymański, W., Ourailidou, M. E., Velema, W. A., Dekker, F. J., & Feringa, B. L. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502809 · Cited by 152
Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors
Guerrant, W., Patil, V., Canzoneri, J. C., & Oyelere, A. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm200799p · Cited by 149
Epigenetic control of gene regulation in plants
Lauria, M., & Rossi, V. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.03.002 · Cited by 147
Development of a histone deacetylase 6 inhibitor and its biological effects
Lee, J.-H., Mahendran, A., Yao, Y., Ngo, L., Venta-Perez, G., Choy, M. L., Kim, N., Ham, W.-S., Breslow, R., & Marks, P. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313893110 · Cited by 141
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
Valente, S., Trisciuoglio, D., Luca, T. D., Nebbioso, A., Labella, D., Lenoci, A., Bigogno, C., Dondio, G. M., Miceli, M., Brosch, G., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500303u · Cited by 138
Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance
Robey, R. W., Chakraborty, A. R., Basseville, A., Luchenko, V. L., Bahr, J. C., Zhan, Z., & Bates, S. E. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200329f · Cited by 135
Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
Kalin, J. H., & Bergman, J. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4001659 · Cited by 135
Reduced Body Size and Decreased Intestinal Tumor Rates in HDAC2-Mutant Mice
Zimmermann, S., Kiefer, F., Prudenziati, M., Spiller, C., Hansen, J., Floß, T., Wurst, W., Minucci, S., & Göttlicher, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0312 · Cited by 132
Heimburg, T., Chakrabarti, A., Lancelot, J., Marek, M., Melesina, J., Hauser, A.-T., Shaik, T. B., Duclaud, S., Robaa, D., Erdmann, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01478 · Cited by 124
HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG‐I
Choi, S. J., Lee, H., Kim, J., Park, S. Y., Kim, T., Lee, W., Jang, D., Yoon, J., Choi, Y., Kim, S., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592586 · Cited by 123
Structural Origin of Selectivity in Class II-Selective Histone Deacetylase Inhibitors
Estiu, G. L., Greenberg, E. F., Harrison, C. B., Kwiatkowski, N. P., Mazitschek, R., Bradner, J. E., & Wiest, O. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015254 · Cited by 119
Rodrigues, D. A., Ferreira‐Silva, G. Á., Ferreira, A. C. S., Fernandes, R. A., Kwee, J. K., Sant’Anna, C. M. R., Ionta, M., & Fraga, C. A. M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01525 · Cited by 119
Investigating the Selectivity of Metalloenzyme Inhibitors
Day, J. A., & Cohen, S. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401053m · Cited by 109
Wu, R., Lu, Z., Cao, Z., & Zhang, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111104p · Cited by 108
Kim, S. W., Hooker, J. M., Otto, N., Win, K., Muench, L., Shea, C., Carter, P., King, P., Reid, A. E., Volkow, N. D., et al. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.06.007 · Cited by 104
Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity
Gryder, B. E., Rood, M. K., Johnson, K. A., Patil, V., Raftery, E. D., Yao, L.-P. D., Rice, M., Azizi, B., Doyle, D. F., & Oyelere, A. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400467w · Cited by 102
Park, J., Kim, S.-H., Choi, M.-C., Lee, J., Oh, D., Im, S., Bang, Y., & Kim, T.-Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.056 · Cited by 99
Mahboobi, S., Sellmer, A., Winkler, M., Eichhorn, E., Pongratz, H., Ciossek, T., Baer, T., Maier, T. M., & Beckers, T. L. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100665z · Cited by 99
Duan, W., Li, J., Inks, E. S., Chou, C. J., Jia, Y., Chu, X., Li, X., Xu, W., & Zhang, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00317 · Cited by 98
Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
Olson, D. E., Wagner, F. F., Kaya, T., Gale, J. P., Aidoud, N., Davoine, E. L., Lazzaro, F., Weïwer, M., Zhang, Y., & Holson, E. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400390r · Cited by 98
Wang, H., Yu, N., Chen, D., Lee, K. C. L., Lye, P. L., Chang, J. W. W., Deng, W., Ng, M., Lu, T., Khoo, M. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2003552 · Cited by 94
Chandran, A., Antony, C., Jose, L., Mundayoor, S., Natarajan, K., & Kumar, R. A. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00090 · Cited by 91
Souto, J. A., Vaz, E., Lepore, I., Pöppler, A., Franci, G., Álvarez, R., Altucci, L., & de Lera, Á. R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100244y · Cited by 90
Baba, R., Hori, Y., Mizukami, S., & Kikuchi, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306045j · Cited by 88
Zhang, X., Kong, Y., Zhang, J., Su, M., Zhou, Y., Zang, Y., Li, J. X., Chen, Y., Fang, Y., Zhang, X., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.035 · Cited by 87
Thangapandian, S., John, S., Sakkiah, S., & Lee, K. W. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.06.024 · Cited by 87
Ye, R., Ke, Z., Tan, C., He, L., Ji, L., & Mao, Z. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300814 · Cited by 86
Lee, H., Tsai, A.-C., Chen, M.-C., Shen, P.-J., Cheng, Y.-C., Kuo, C., Pan, S., Liu, Y.-M., Liu, J.-F., Yeh, T., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401899x · Cited by 85
Hansen, F. K., Sumanadasa, S. D. M., Stenzel, K., Duffy, S., Meister, S., Marek, L., Schmetter, R., Kuna, K., Hamacher, A., Mordmüller, B. G., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.050 · Cited by 82
Chen, J.-B., Chern, T., Wei, T.-T., Chen, C., Lin, J., & Fang, J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400179b · Cited by 81
Structural basis for the design and synthesis of selective HDAC inhibitors
Micco, S. D., Chini, M. G., Terracciano, S., Bruno, I., Riccio, R., & Bifulco, G. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.036 · Cited by 80
Li, D., Xie, S., Ren, Y., Huo, L., Gao, J., Cui, D., Liu, M., & Zhou, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1015-4 · Cited by 79
Li, Y., Peng, L., & Seto, E. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00400-15 · Cited by 76
Li, X., Inks, E. S., Li, X., Hou, J., Chou, C. J., Zhang, J., Jiang, Y., Zhang, Y., & Xu, W. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401877m · Cited by 76
3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition
Patil, V., Sodji, Q. H., Kornacki, J. R., Mrksich, M., & Oyelere, A. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301769u · Cited by 75
Histone Acylation beyond Acetylation: Terra Incognita in Chromatin Biology.
Rousseaux, S., & Khochbin, S. (2015) · PubMed Central · doi:10.22074/cellj.2015.506 · Cited by 75
NO sparks off chromatin: Tales of a multifaceted epigenetic regulator
Illi, B., Colussi, C., Grasselli, A., Farsetti, A., Capogrossi, M. C., & Gaetano, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.003 · Cited by 74
Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors
Gryder, B. E., Akbashev, M. J., Rood, M. K., Raftery, E. D., Meyers, W. M., Dillard, P., Khan, S. A., & Oyelere, A. K. (2013) · ACS Chemical Biology · doi:10.1021/cb400542w · Cited by 73
He, R. L., Chen, Y., Chen, Y., Ougolkov, A. V., Zhang, J., Savoy, D. N., Billadeau, D. D., & Kozikowski, A. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901667k · Cited by 71
Pompo, G. D., Salerno, M., Rotili, D., Valente, S., Zwergel, C., Avnet, S., Lattanzi, G., Baldini, N., & Mai, A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00126 · Cited by 68
General Base–General Acid Catalysis in Human Histone Deacetylase 8
Gantt, S. M. L., Decroos, C., Lee, M. S., Gullett, L. E., Bowman, C. M., Christianson, D. W., & Fierke, C. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01327 · Cited by 67
Ontoria, J. M., Altamura, S., Marco, A. D., Ferrigno, F., Laufer, R., Muraglia, E., Palumbi, M. C., Rowley, M., Scarpelli, R., Schultz‐Fademrecht, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900555u · Cited by 65
Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors
Shultz, M. D., Cao, X., Chen, C. H., Cho, Y. S., Davis, N. R., Eckman, J., Fan, J., Fekete, A., Firestone, B., Flynn, J., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200388e · Cited by 65
Image-Guided Synthesis Reveals Potent Blood-Brain Barrier Permeable Histone Deacetylase Inhibitors
Seo, Y. J., Kang, Y., Muench, L., Reid, A. E., Caesar, S., Jean, L., Wagner, F. F., Holson, E. B., Haggarty, S. J., Weiss, P., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500021p · Cited by 63
Inhibition and Mechanism of HDAC8 Revisited
Chen, K., Zhang, X., Wu, Y., & Wiest, O. (2014) · Journal of the American Chemical Society · doi:10.1021/ja501548p · Cited by 63
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Tang, G., Wong, J. C., Zhang, W., Wang, Z., Zhang, N., Peng, Z., Zhang, Z., Rong, Y., Li, S., Zhang, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008962 · Cited by 62
Yao, Y., Liao, C., Li, Z., Wang, Z., Sun, Q., Liu, C., Yang, Y., Tu, Z., & Jiang, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.024 · Cited by 61
Radhakrishnan, R., Li, Y., Xiang, S., Yuan, F., Yuan, Z., Telles, E., Fang, J., Coppola, D., Shibata, D., Lane, W. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612945 · Cited by 60
Decroos, C., Clausen, D. J., Haines, B. E., Wiest, O., Williams, R. M., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00010 · Cited by 58
Marson, C. M., Matthews, C. J., Yiannaki, E., Atkinson, S. J., Soden, P. E., Shukla, L., Lamadema, N., & Thomas, N. S. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400634n · Cited by 56
Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Nam, N., Huong, T. L., Dung, D. T. M., Dung, P. T. P., Oanh, D. T. K., Quyen, D., Thảo, L. T. P., Park, S. H., Kim, K. R., Han, B. W., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.045 · Cited by 55
Park, H., Kim, S., Kim, Y. E., & Lim, S. (2010) · ChemMedChem · doi:10.1002/cmdc.200900500 · Cited by 52
Salmi, C., Fabre, A. J., Dequiedt, F., Restouin, A., Castellano, R., Garbit, S., Roche, P., Morelli, X., Brunel, J. M., & Collette, Y. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901358y · Cited by 50
Wambua, M. K., Nalawansha, D. A., Negmeldin, A. T., & Pflum, M. K. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401837e · Cited by 49
Pottel, J., Therrien, E., Gleason, J. L., & Moitessier, N. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400550m · Cited by 48
Tùng, T. T., Oanh, D., Dung, P. P., Huệ, V. T. M., Park, S., Han, B. W., Kim, Y. S., Hong, J. T., Han, S., & Nam, N. (2013) · Medicinal Chemistry · doi:10.2174/15734064113099990027 · Cited by 47
Computational Design of a Time-Dependent Histone Deacetylase 2 Selective Inhibitor
Zhou, J., Li, M., Chen, N., Wang, S., Luo, H., Zhang, Y., & Wu, R. (2014) · ACS Chemical Biology · doi:10.1021/cb500767c · Cited by 47
The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase
Zhang, X., Bao, B., Yu, X., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.023 · Cited by 46
Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase Inhibitor
Borretto, E., Lazzarato, L., Spallotta, F., Cencioni, C., D’Alessandra, Y., Gaetano, C., Fruttero, R., & Gasco, A. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400289e · Cited by 46
Blackburn, C., Barrett, C., Chin, J. E., Garcia, K., Gigstad, K. M., Gould, A. E., Gutierrez, J. A., Harrison, S., Hoar, K. M., Lynch, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400385r · Cited by 45
Discovery of adamantane based highly potent HDAC inhibitors
Gopalan, B., Ponpandian, T., Kachhadia, V. V., Bharathimohan, K., Radhakrishnan, V., Sivasudar, V., Narayanan, S., Mandar, B., Rajendran, P., Saranya, N., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.002 · Cited by 44
Hou, X., Du, J., Liu, R., Zhou, Y., Li, M., Xu, W., & Fang, H. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500762z · Cited by 44
Improved Synthesis and Structural Reassignment of MC1568: A Class IIa Selective HDAC Inhibitor
Fleming, C. L., Ashton, T. D., Gaur, V., McGee, S. L., & Pfeffer, F. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401945k · Cited by 44
Design and Synthesis of Orally Bioavailable Aminopyrrolidinone Histone Deacetylase 6 Inhibitors
Lin, X., Chen, W.-M., Qiu, Z., Guo, L., Zhu, W., Li, W., Wang, Z., Zhang, W., Zhang, Z., Rong, Y., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm502011f · Cited by 44
Soragni, E., Xu, C., Plasterer, H. L., Jacques, V., Rusche, J. R., & Gottesfeld, J. M. (2012) · Journal of Child Neurology · doi:10.1177/0883073812448533 · Cited by 44
Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
Kong, Y., Jung, M., Wang, K., Grindrod, S. C., Velena, A., Lee, S. A., Dakshanamurthy, S., Yang, Y., Miessau, M., Zheng, C., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0779 · Cited by 44
Singh, P., Mandal, T., Balasubramanian, N., Cook, G. R., & Srivastava, D. K. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.08.040 · Cited by 43
Bhansali, P. R., Hanigan, C. L., Casero, R. A., & Tillekeratne, L. M. V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200432a · Cited by 43
Hou, J., Li, Z., Fang, Q., Feng, C., Zhang, H., Guo, W., Wang, H. H., Gu, G., Tian, Y., Liu, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201496g · Cited by 43
Huang, W., Chen, C., Chao, S.-W., Lee, S., Hsu, F., Lu, Y., Hung, M., & Chang, C. (2010) · ChemMedChem · doi:10.1002/cmdc.200900494 · Cited by 42
Ning, C., Lu, C., Hu, L., Bi, Y.-J., Yao, L., He, Y., Liu, L., Liu, X., & Yu, N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.034 · Cited by 41
Abdel-Atty, M. M., Farag, N. A., Kassab, S. E., Serya, R. A. T., & Abouzid, K. A. M. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.08.006 · Cited by 41
Villadsen, J. S., Stephansen, H. M., Maolanon, A. R., Harris, P., & Olsen, C. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4008449 · Cited by 41
Loop Interactions and Dynamics Tune the Enzymatic Activity of the Human Histone Deacetylase 8
Kunze, M. B. A., Wright, D. W., Werbeck, N. D., Kirkpatrick, J., Coveney, P. V., & Hansen, D. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408184x · Cited by 41
Saha, A., Pandian, G. N., Sato, S., Taniguchi, J., Hashiya, K., Bando, T., & Sugiyama, H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.002 · Cited by 39
Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors
Tashima, T., Murata, H., & Kodama, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.05.001 · Cited by 38
Huang, W., Chen, C., Chao, S.-W., Yu, C.-C., Yang, C., Guh, J., Lin, Y.-C., Kuo, C.-I., Yang, P., & Chang, C.-I. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.06.002 · Cited by 37
Yang, F., Zhang, T., Wu, H., Yang, Y., Liu, N., Chen, A., Li, Q., Li, J., Qin, L., Jiang, B., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5012148 · Cited by 37
Sodji, Q. H., Patil, V., Kornacki, J. R., Mrksich, M., & Oyelere, A. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401225q · Cited by 36
Wang, C., Eessalu, T. E., Barth, V., Mitch, C. H., Wagner, F. F., Hong, Y., Neelamegam, R., Schroeder, F. A., Holson, E. B., Haggarty, S. J., et al. (2013) · Europe PMC (PubMed Central) · Cited by 35
Evaluation of class I HDAC isoform selectivity of largazole analogues
Kim, B., Park, H., Salvador, L. A., Serrano, P. E., Kwan, J. C., Zeller, S. L., Chen, Q.-Y., Ryu, S., Liu, Y., Byeon, S., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.006 · Cited by 35
The Design and Synthesis of a New Class of RTK/HDAC Dual-Targeted Inhibitors
Zhang, X., Su, M., Chen, Y., Li, J. X., & Lu, W. P. (2013) · Molecules · doi:10.3390/molecules18066491 · Cited by 35
Thaler, F., Colombo, A., Mai, A., Amici, R., Bigogno, C., Boggio, R., Cappa, A., Carrara, S., Cataudella, T., Fusar, F., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901502p · Cited by 34
Class I HDAC imaging using [3H]CI-994 autoradiography
Wang, Y., Zhang, Y., Hennig, K. M., Gale, J. P., Hong, Y., Cha, A., Riley, M. M., Wagner, F. F., Haggarty, S. J., Holson, E. B., et al. (2013) · Epigenetics · doi:10.4161/epi.25202 · Cited by 34
Seo, Y. J., Muench, L., Reid, A. E., Chen, J., Kang, Y., Hooker, J. M., Volkow, N. D., Fowler, J. S., & Kim, S. W. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.038 · Cited by 32
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs
Guerra-Bubb, J. M., Bowers, A. A., Smith, W. B., Paranal, R. M., Estiu, G. L., Wiest, O., Bradner, J. E., & Williams, R. M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.012 · Cited by 31
Ilies, M., Dowling, D., Lombardi, P. M., & Christianson, D. W. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.100 · Cited by 31
Terracciano, S., Micco, S. D., Bifulco, G., Gallinari, P., Riccio, R., & Bruno, I. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.022 · Cited by 30
Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors
Tan, Q., Zhang, Z., Jie, H., Zhao, Y. C., & Zhu, L. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.021 · Cited by 29
Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer
Riester, D., Hildmann, C., Schwienhorst, A., & Meyer‐Almes, F. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2006.12.019 · Cited by 29
Choi, S. E., & Pflum, M. K. H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.093 · Cited by 28
Choi, S. E., Weerasinghe, S. V. W., & Pflum, M. K. H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.027 · Cited by 28
A Chimeric SERM–Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy
Patel, H., Siklos, M. I., Abdelkarim, H., Mendonca, E. L., Vaidya, A. S., Petukhov, P. A., & Thatcher, G. R. J. (2013) · ChemMedChem · doi:10.1002/cmdc.201300270 · Cited by 27
Sekizawa, H., Amaike, K., Itoh, Y., Suzuki, T., Itami, K., & Yamaguchi, J. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500024s · Cited by 27
Histone Deacetylase Inhibitors: Structure-Based Modeling and Isoform-Selectivity Prediction
Silvestri, L., Ballante, F., Mai, A., Marshall, G. R., & Ragno, R. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300160y · Cited by 26
Ning, C., Bi, Y.-J., He, Y., Huang, W., Liu, L., Li, Y., Zhang, S.-H., Liu, X., & Yu, N. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.051 · Cited by 26
An HDAC-Targeted Imaging Probe LBH589–Cy5.5 for Tumor Detection and Therapy Evaluation
Meng, Q., Liu, Z., Li, F., Ma, J., Wang, H., Huan, Y., & Li, Z. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00167 · Cited by 26
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.05.002 · Cited by 25
Zhang, L., Zhang, Y., Chou, C. J., Inks, E. S., Wang, X., Li, X., Hou, J., & Xu, W. (2013) · ChemMedChem · doi:10.1002/cmdc.201300297 · Cited by 24
A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold
Kemp, M. M., Wang, Q., Fuller, J. H., West, N. H., Martínez, N. M., Morse, E. M., Weïwer, M., Schreiber, S. L., Bradner, J. E., & Koehler, A. N. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.098 · Cited by 24
Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors
Taddei, M., Cini, E., Giannotti, L., Giannini, G., Battistuzzi, G., Vignola, D., Vesci, L., & Cabri, W. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.072 · Cited by 24
Yang, W., Li, L., Ji, X., Wu, X., Su, M., Li, S., Zang, Y., Li, J. X., & Liu, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.030 · Cited by 24
Wang, T., Sepulveda, M., Gonzales, P. A., & Gately, S. T. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.07.001 · Cited by 23
Feng, T., Wang, H., Su, H. L., Lu, H., Yu, L., Zhang, X., Sun, H., & You, Q. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.009 · Cited by 23
Bahhaj, F. E., Dekker, F. J., Martinet, N., & Bertrand, P. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.017 · Cited by 23
Self-citationRajak, H., Kumar, P., Parmar, P., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.058 · Cited by 23
Meyners, C., Baud, M. G. J., Fuchter, M. J., & Meyer‐Almes, F. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.05.014 · Cited by 22
Bhansali, P. R., Hanigan, C. L., Perera, L., Casero, R. A., & Tillekeratne, L. M. V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.009 · Cited by 22
Divergent Kinetics Differentiate the Mechanism of Action of Two HDAC Inhibitors
Kral, A. M., Ozerova, N. D. S., Close, J., Jung, J. O., Chénard, M., Fleming, J. C., Haines, B. B., Harrington, P., Maclean, J. K. F., Miller, T. A., et al. (2014) · Biochemistry · doi:10.1021/bi400936h · Cited by 22
Novel 64Cu-Labeled CUDC-101 for in Vivo PET Imaging of Histone Deacetylases
Meng, Q., Li, F., Jiang, S., & Li, Z. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400191z · Cited by 21
Fluorescent analogs of the marine natural product psammaplin A: synthesis and biological activity
Hentschel, F., Sasse, F., & Lindel, T. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25909e · Cited by 21
Methyl Effect in Azumamides Provides Insight Into Histone Deacetylase Inhibition by Macrocycles
Maolanon, A. R., Villadsen, J. S., Christensen, N. J., Hoeck, C. R., Friis, T., Harris, P., Gotfredsen, C. H., Fristrup, P., & Olsen, C. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501399d · Cited by 20
Sun, Q., Yao, Y., Liu, C., Li, H., Yao, H., Xue, X., Liu, J., Tu, Z., & Jiang, S. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.102 · Cited by 18
Zeglis, B. M., Pillarsetty, N., Divilov, V., Blasberg, R., & Lewis, J. S. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.12.008 · Cited by 18
Growth attenuation is associated with histone deacetylase 10-induced autophagy in the liver
Pinto, G., Shtaif, B., Phillip, M., & Gat‐Yablonski, G. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.031 · Cited by 17
Thaler, F., Varasi, M., Abate, A., Carenzi, G. E. A., Colombo, A., Bigogno, C., Boggio, R., Zuffo, R. D., Rapetti, D., Resconi, A., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.061 · Cited by 17
Musso, L., Cincinelli, R., Zuco, V., Zunino, F., Nurisso, A., Cuendet, M., Giannini, G., Vesci, L., Pisano, C., & Dallavalle, S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.006 · Cited by 16
Singh, P., Suzuki, T., Mandal, T., Balsubramanian, N., Haldar, M., Mueller, D. J., Strode, J. A., Cook, G. R., Mallik, S., & Srivastava, D. K. (2014) · Biochemistry · doi:10.1021/bi500711x · Cited by 16
Fan, W., Huang, J., & Xiao, H. (2015) · Europe PMC (PubMed Central) · Cited by 15
Peng, Z., & Kopeček, J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.006 · Cited by 14
Tu, S., Yuan, H., Hu, J., Zhao, C., Chai, R., & Cao, H. (2014) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c14-00449 · Cited by 14
Canzoneri, J. C., Chen, P. C., & Oyelere, A. K. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.028 · Cited by 12
Chan, C. T., Qi, J., Smith, W., Paranol, R., Mazitschek, R., West, N. H., Reeves, R. E., Chiosis, G., Schreiber, S. L., Bradner, J. E., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0197 · Cited by 12
Marastoni, E., Bartoli, S., Berettoni, M., Cipollone, A., Ettorre, A., Fincham, C. I., Mauro, S., Paris, M., Porcelloni, M., Bigioni, M., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.053 · Cited by 10
Novel Folate-Hydroxamate Based Antimetabolites: Synthesis and Biological Evaluation
Carrasco, M. P., Enyedy, É. A., Krupenko, N. I., Krupenko, S. A., Nuti, E., Tuccinardi, T., Santamaria, S., Rossello, A., Martinelli, A., & Santos, M. A. (2011) · Medicinal Chemistry · doi:10.2174/157340611796150923 · Cited by 9
Superacid and thiol-ene reactions for access to psammaplin analogues with HDAC inhibition activities
Bahhaj, F. E., Désiré, J., Blanquart, C., Martinet, N., Zwick, V., Simões‐Pires, C. A., Cuendet, M., Grégoire, M., & Bertrand, P. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.10.053 · Cited by 6
Self-citationAn efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors
Islam, M. S., Islam, M. N., Hoque, M. A., Nishino, N., Kato, T., Kim, H., Ito, A., & Yoshida, M. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.02.009 · Cited by 5
A cyclodextrin-capped histone deacetylase inhibitor
Amin, J., Puglisi, A., Clarke, J., Milton, J., Wang, M., Paranal, R. M., Bradner, J. E., & Spencer, J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.084 · Cited by 5
Discovering the Binding Modes of Natural Products with Histone Deacetylase 1
Zhang, L., Li, M., Zhang, L., & Xu, W. (2012) · Medicinal Chemistry · doi:10.2174/157340613804488314 · Cited by 3
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation
Gibb, A. A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 434
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Bondarev, A. D., Attwood, M. M., Jonsson, J., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14889 · Cited by 416
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
He, Y., Xu, W., Xiao, Y.-T., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 261
Metadata
- Authors
- Roche, J., & Bertrand, P.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 121
- Pages
- 451-483
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2404368222
- Cited by
- 312
- References
- 183
- FWCI
- 16.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.